Zkusit zdarma
Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc.

MIRM
Cena:
$ 98.62
-2.05 (-2.04%)
Valuace
70
Růst
0
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Mirum Pharmaceuticals to Present Data Showcasing Leadership in Rare Liver Diseases at the EASL International Liver Congress 2026

Mirum Pharmaceuticals to Present Data Showcasing Leadership in Rare Liver Diseases at the EASL International Liver Congress 2026

8:05 21-05-2026

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals to Present Data Showcasing Leadership in...

Mirum Pharma: A Rare Disease Growth Story to Watch

Mirum Pharma: A Rare Disease Growth Story to Watch

12:35 20-05-2026

Mirum Pharmaceuticals NASDAQ: MIRM is a late-stage biotechnology company that is making significant ...

Mirum Pharmaceuticals Prices $600.0 Million Convertible Senior Notes Offering; Refinances a Portion of 2029 Convertible Notes

Mirum Pharmaceuticals Prices $600.0 Million Convertible Senior Notes Offering; Refinances a Portion of 2029 Convertible Notes

23:56 12-05-2026

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Prices $600.0 Million Convertible Senior...

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences

8:00 12-05-2026

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals to Participate in Upcoming Investor Conf...

Mirum's Q1 Earnings & Revenues Beat Estimates, 2026 View Raised

Mirum's Q1 Earnings & Revenues Beat Estimates, 2026 View Raised

13:06 07-05-2026

MIRM beats Q1 earnings and revenue estimates as Livmarli and bile acid drugs fuel growth, prompting ...

Mirum Pharmaceuticals, Inc. (MIRM) Q1 2026 Earnings Call Transcript

Mirum Pharmaceuticals, Inc. (MIRM) Q1 2026 Earnings Call Transcript

23:21 06-05-2026

Mirum Pharmaceuticals, Inc. (MIRM) Q1 2026 Earnings Call Transcript...

Here's What Key Metrics Tell Us About Mirum Pharmaceuticals (MIRM) Q1 Earnings

Here's What Key Metrics Tell Us About Mirum Pharmaceuticals (MIRM) Q1 Earnings

19:01 06-05-2026

Although the revenue and EPS for Mirum Pharmaceuticals (MIRM) give a sense of how its business perfo...

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q1 Loss, Beats Revenue Estimates

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q1 Loss, Beats Revenue Estimates

18:25 06-05-2026

Mirum Pharmaceuticals, Inc. (MIRM) came out with a quarterly loss of $0.39 per share versus the Zack...

Mirum Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update

Mirum Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update

16:01 06-05-2026

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports First Quarter 2026 Financial Res...

Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Clinical Results in Primary Sclerosing Cholangitis and Hepatitis Delta Transcript

Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Clinical Results in Primary Sclerosing Cholangitis and Hepatitis Delta Transcript

20:43 04-05-2026

Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Clinical Results in Primary Sclerosing Cholangi...

Mirum's rare liver disease drug meets main goal in mid-stage study

Mirum's rare liver disease drug meets main goal in mid-stage study

14:04 04-05-2026

Mirum Pharmaceuticals said on Monday its experimental drug, volixibat, met the main goal of ​a mid...

Mirum Pharmaceuticals Rally Reflects Confidence In Late-Stage Liver Disease Assets

Mirum Pharmaceuticals Rally Reflects Confidence In Late-Stage Liver Disease Assets

11:15 04-05-2026

Mirum Pharmaceuticals Inc. (NASDAQ:MIRM) shares are up on Monday following the announcement that the...

Mirum Pharmaceuticals Announces Primary Endpoint Met in VISTAS Study of Volixibat in Patients with Primary Sclerosing Cholangitis

Mirum Pharmaceuticals Announces Primary Endpoint Met in VISTAS Study of Volixibat in Patients with Primary Sclerosing Cholangitis

8:00 04-05-2026

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Announces Primary Endpoint Met in VISTAS...

Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the VISTAS Study of Volixibat in Patients with Primary Sclerosing Cholangitis on May 4, 2026

Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the VISTAS Study of Volixibat in Patients with Primary Sclerosing Cholangitis on May 4, 2026

17:00 03-05-2026

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals to Host Investor Call to Share Topline R...

Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 2b Portion of the AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Virus

Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 2b Portion of the AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Virus

8:00 27-04-2026

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase ...

2 Under-the-Radar Biotech Stocks Worth Buying for the Long Term

2 Under-the-Radar Biotech Stocks Worth Buying for the Long Term

9:45 19-04-2026

Vertex Pharmaceuticals has shown steady financial growth. Mirum Pharmaceuticals is getting closer to...

Will Livmarli Continue to Aid Mirum's Top Line in Q1 Earnings?

Will Livmarli Continue to Aid Mirum's Top Line in Q1 Earnings?

12:41 17-04-2026

MIRM heads into Q1 earnings with Livmarli sales in focus after 69% year-over-year growth in 2025. Bi...

Prediction: Buying This Biotech Stock Today Could Set You Up for Life

Prediction: Buying This Biotech Stock Today Could Set You Up for Life

5:43 13-04-2026

Mirum Pharmaceuticals already markets three therapies. The company plans to report four pivotal read...

Egetis Appoints Tiago Nunes as Chief Medical Officer

Egetis Appoints Tiago Nunes as Chief Medical Officer

1:15 09-04-2026

STOCKHOLM, SE / ACCESS Newswire / April 9, 2026 / Egetis Therapeutics AB (publ) ("Egetis" or the "Co...

18,710 Shares in Mirum Pharmaceuticals, Inc. $MIRM Purchased by SG Americas Securities LLC

18,710 Shares in Mirum Pharmaceuticals, Inc. $MIRM Purchased by SG Americas Securities LLC

5:07 07-04-2026

SG Americas Securities LLC acquired a new stake in Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) during...

close

MIRUM PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

10-02-2026
FOSTER CITY, CALIF.--(BUSINESS WIRE)--MIRUM PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ L...
Více zde

MIRUM PHARMACEUTICALS ANNOUNCES HEALTH CANADA AUTHORIZATION OF LIVMARLI® TABLET FORMULATION FOR THE TREATMENT OF CHOLESTATIC PRURITUS IN PATIENTS WITH ALAGILLE SYNDROME

05-02-2026
TORONTO--(BUSINESS WIRE)--MIRUM ANNOUNCES HEALTH CANADA AUTHORIZATION OF LIVMARLI® TABLET FORMULATI...
Více zde

MIRUM PHARMACEUTICALS ANNOUNCES HEALTH CANADA AUTHORIZATION OF LIVMARLI® FOR THE TREATMENT OF CHOLESTATIC PRURITUS IN PATIENTS WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS (PFIC)

05-02-2026
TORONTO--(BUSINESS WIRE)--HEALTH CANADA AUTHORIZES MIRUM'S LIVMARLI® FOR THE TREATMENT OF CHOLESTAT...
Více zde

MIRUM PHARMACEUTICALS COMPLETES ACQUISITION OF BLUEJAY THERAPEUTICS, EXPANDING GLOBAL LEADERSHIP IN RARE DISEASE

26-01-2026
FOSTER CITY, CALIF.--(BUSINESS WIRE)--MIRUM PHARMACEUTICALS COMPLETES ACQUISITION OF BLUEJAY THERAPE...
Více zde

MIRUM PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

12-01-2026
FOSTER CITY, CALIF.--(BUSINESS WIRE)--MIRUM PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ L...
Více zde

MIRUM PHARMACEUTICALS ANNOUNCES PRELIMINARY UNAUDITED 2025 RESULTS, DEMONSTRATING STRONG COMMERCIAL GROWTH AND PIPELINE MOMENTUM

12-01-2026
FOSTER CITY, CALIF.--(BUSINESS WIRE)--MIRUM PHARMACEUTICALS ANNOUNCES PRELIMINARY UNAUDITED 2025 RES...
Více zde

ENTHORIN THERAPEUTICS ANNOUNCES INITIATION OF PHASE II CLINICAL TRIAL OF MRM-3379 (FORMERLY ENT-3379) FOR FRAGILE X SYNDROME BY LICENSING PARTNER MIRUM PHARMACEUTICALS

09-01-2026
ESCONDIDO, CALIF.--(BUSINESS WIRE)--ENTHORIN THERAPEUTICS, LLC, A BIOTECHNOLOGY COMPANY FOCUSED ON C...
Více zde

MIRUM PHARMACEUTICALS TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

07-01-2026
FOSTER CITY, CALIF.--(BUSINESS WIRE)--MIRUM PHARMACEUTICALS TO PRESENT AT THE 44TH ANNUAL J.P. MORGA...
Více zde

MIRUM PHARMACEUTICALS ANNOUNCES ADDITIONAL PRIVATE PLACEMENT FINANCING WITH TCGX

19-12-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--MIRUM PHARMACEUTICALS ANNOUNCES ADDITIONAL PRIVATE PLACEMENT F...
Více zde

MIRUM PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

10-12-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--MIRUM PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ L...
Více zde

MIRUM PHARMACEUTICALS ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE BLUEJAY THERAPEUTICS, EXPANDING GLOBAL LEADERSHIP IN RARE DISEASE

08-12-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--MIRUM PHARMACEUTICALS, INC. (NASDAQ: MIRM), A LEADING RARE DIS...
Více zde

MIRUM PHARMACEUTICALS ANNOUNCES FIRST PATIENT ENROLLED IN THE BLOOM PHASE 2 CLINICAL STUDY EVALUATING MRM-3379 IN FRAGILE X SYNDROME

01-12-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--MIRUM PHARMACEUTICALS, INC. (NASDAQ: MIRM), A LEADING RARE DIS...
Více zde

MIRUM PHARMACEUTICALS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

25-11-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--MIRUM PHARMACEUTICALS, INC. (NASDAQ: MIRM), A BIOPHARMACEUTICA...
Více zde

MIRUM PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

10-11-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--MIRUM PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ L...
Více zde

MIRUM PHARMACEUTICALS SHOWCASES LEADERSHIP IN LIVER DISEASE INNOVATION WITH DATA FROM LIVMARLI® AND VOLIXIBAT CLINICAL PROGRAMS AT AASLD'S THE LIVER MEETING®

07-11-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--MIRUM PHARMA SHOWCASES LEADERSHIP IN LIVER DISEASE INNOVATION ...
Více zde

MIRUM PHARMACEUTICALS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

04-11-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--MIRUM PHARMACEUTICALS REPORTS THIRD QUARTER 2025 FINANCIAL RES...
Více zde

MIRUM PHARMACEUTICALS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

03-11-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--MIRUM PHARMACEUTICALS TO PARTICIPATE IN UPCOMING INVESTOR CONF...
Více zde

MIRUM PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2025 FINANCIAL RESULTS AND HOST CONFERENCE CALL ON NOVEMBER 4, 2025

28-10-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--MIRUM PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2025 FINANCIAL...
Více zde

MIRUM PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

10-10-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--MIRUM PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ L...
Více zde

MIRUM PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

10-09-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--MIRUM PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ L...
Více zde

MIRUM PHARMACEUTICALS ANNOUNCES ENROLLMENT COMPLETION IN THE PHASE 2B VISTAS STUDY

08-09-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--MIRUM PHARMACEUTICALS, INC. (NASDAQ: MIRM) TODAY ANNOUNCED THE...
Více zde

MIRUM PHARMACEUTICALS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

27-08-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--MIRUM PHARMACEUTICALS TO PARTICIPATE IN UPCOMING INVESTOR CONF...
Více zde

MIRUM PHARMACEUTICALS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

06-08-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--MIRUM PHARMACEUTICALS REPORTS SECOND QUARTER 2025 FINANCIAL RE...
Více zde

MIRUM PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

10-07-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--MIRUM PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ L...
Více zde

MIRUM PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

10-06-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--MIRUM PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ L...
Více zde

MIRUM PHARMACEUTICALS APPOINTS DOUG SHEEHY, JD, AS CHIEF LEGAL OFFICER

19-05-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)---- $MIRM #LEADERSHIP--MIRUM PHARMACEUTICALS APPOINTS DOUG SHEE...
Více zde

MIRUM PHARMACEUTICALS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

14-05-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--MIRUM PHARMACEUTICALS, INC. (NASDAQ: MIRM), A BIOPHARMACEUTICA...
Více zde

MIRUM PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

09-05-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--MIRUM PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ L...
Více zde

VOLIXIBAT DATA FROM MIRUM'S VANTAGE PBC STUDY SHOWCASED AT EASL

09-05-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)---- $MIRM #EASL2025--VOLIXIBAT DATA FROM MIRUM'S VANTAGE PBC ST...
Více zde

MIRUM PHARMACEUTICALS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

07-05-2025
FOSTER CITY, CALIF.--(BUSINESS WIRE)--MIRUM PHARMACEUTICALS REPORTS FIRST QUARTER 2025 FINANCIAL RES...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-26 00:00:008-KStáhnout
2026-01-12 00:00:008-KStáhnout
2025-12-19 00:00:008-KStáhnout
2025-12-08 00:00:008-KStáhnout
2025-11-17 00:00:008-KStáhnout
2025-11-04 00:00:008-KStáhnout
2025-11-04 00:00:0010-QStáhnout
2025-08-06 01:00:008-KStáhnout
2025-08-06 01:00:0010-QStáhnout
2025-08-06 00:00:008-KStáhnout
2025-08-06 00:00:0010-QStáhnout
2025-05-30 01:00:008-KStáhnout
2025-05-30 00:00:008-KStáhnout
2025-05-07 01:00:008-KStáhnout
2025-05-07 01:00:0010-QStáhnout
2025-05-07 00:00:008-KStáhnout
2025-05-07 00:00:0010-QStáhnout
2025-02-26 00:00:008-KStáhnout
2025-02-26 00:00:0010-KStáhnout
2025-02-25 23:00:008-KStáhnout
2025-02-25 23:00:0010-KStáhnout
2025-01-13 00:00:008-KStáhnout
2025-01-12 23:00:008-KStáhnout
2024-11-12 00:00:008-KStáhnout
2024-11-12 00:00:0010-QStáhnout
2024-11-11 23:00:008-KStáhnout
2024-11-11 23:00:0010-QStáhnout
2024-08-07 01:00:008-KStáhnout
2024-08-07 01:00:0010-QStáhnout
2024-08-07 00:00:008-KStáhnout
2024-08-07 00:00:0010-QStáhnout
2024-06-17 01:00:008-KStáhnout
2024-06-17 00:00:008-KStáhnout
2024-06-06 01:00:008-KStáhnout
2024-06-06 00:00:008-KStáhnout
2024-05-31 01:00:008-KStáhnout
2024-05-31 00:00:008-KStáhnout
2024-05-08 01:00:008-KStáhnout
2024-05-08 01:00:0010-QStáhnout
2024-05-08 00:00:008-KStáhnout
2024-05-08 00:00:0010-QStáhnout
2024-03-15 00:00:0010-KStáhnout
2024-03-14 23:00:0010-KStáhnout
2024-02-28 00:00:008-KStáhnout
2024-02-27 23:00:008-KStáhnout
2024-01-16 00:00:008-KStáhnout
2024-01-15 23:00:008-KStáhnout
2024-01-08 00:00:008-KStáhnout
2024-01-07 23:00:008-KStáhnout
2023-12-18 00:00:008-KStáhnout
2023-12-17 23:00:008-KStáhnout
2023-11-02 00:00:008-KStáhnout
2023-11-02 00:00:0010-QStáhnout
2023-11-01 23:00:008-KStáhnout
2023-11-01 23:00:0010-QStáhnout
2023-10-17 01:00:008-KStáhnout
2023-10-17 00:00:008-KStáhnout
2023-10-13 01:00:008-KStáhnout
2023-10-13 00:00:008-KStáhnout
2023-09-11 01:00:008-KStáhnout
2023-09-11 00:00:008-KStáhnout
2023-09-05 01:00:008-KStáhnout
2023-09-05 00:00:008-KStáhnout
2023-08-30 01:00:008-KStáhnout
2023-08-30 00:00:008-KStáhnout
2023-08-07 01:00:0010-QStáhnout
2023-08-07 00:00:0010-QStáhnout
2023-08-03 01:00:008-KStáhnout
2023-08-03 00:00:008-KStáhnout
2023-07-17 01:00:008-KStáhnout
2023-07-17 00:00:008-KStáhnout
2023-06-13 01:00:008-KStáhnout
2023-06-13 00:00:008-KStáhnout
2023-05-04 01:00:008-KStáhnout
2023-05-04 01:00:0010-QStáhnout
2023-05-04 00:00:008-KStáhnout
2023-05-04 00:00:0010-QStáhnout
2023-04-17 01:00:008-KStáhnout
2023-04-17 00:00:008-KStáhnout
2023-04-12 01:00:008-KStáhnout
2023-04-12 00:00:008-KStáhnout
2023-04-06 01:00:008-KStáhnout
2023-04-06 00:00:008-KStáhnout
2023-03-10 00:00:008-KStáhnout
2023-03-09 23:00:008-KStáhnout
2023-03-08 00:00:008-KStáhnout
2023-03-08 00:00:0010-KStáhnout
2023-03-07 23:00:008-KStáhnout
2023-03-07 23:00:0010-KStáhnout
2023-01-09 00:00:008-KStáhnout
2023-01-08 23:00:008-KStáhnout
2022-12-19 00:00:008-KStáhnout
2022-12-18 23:00:008-KStáhnout
2022-12-13 00:00:008-KStáhnout
2022-12-12 23:00:008-KStáhnout
2022-11-29 00:00:008-KStáhnout
2022-11-28 23:00:008-KStáhnout
2022-11-09 00:00:008-KStáhnout
2022-11-09 00:00:0010-QStáhnout
2022-11-08 23:00:008-KStáhnout
2022-11-08 23:00:0010-QStáhnout
2022-10-24 01:00:008-KStáhnout
2022-10-24 00:00:008-KStáhnout
2022-09-02 01:00:008-KStáhnout
2022-09-02 00:00:008-KStáhnout
2022-08-10 01:00:008-KStáhnout
2022-08-10 00:00:008-KStáhnout
2022-08-04 01:00:008-KStáhnout
2022-08-04 01:00:0010-QStáhnout
2022-08-04 00:00:008-KStáhnout
2022-08-04 00:00:0010-QStáhnout
2022-06-06 01:00:008-KStáhnout
2022-06-06 00:00:008-KStáhnout
2022-05-23 01:00:008-KStáhnout
2022-05-23 00:00:008-KStáhnout
2022-05-05 01:00:008-KStáhnout
2022-05-05 01:00:0010-QStáhnout
2022-05-05 00:00:008-KStáhnout
2022-05-05 00:00:0010-QStáhnout
2022-03-09 00:00:008-KStáhnout
2022-03-09 00:00:0010-KStáhnout
2022-03-08 23:00:008-KStáhnout
2022-03-08 23:00:0010-KStáhnout
2022-01-11 00:00:008-KStáhnout
2022-01-10 23:00:008-KStáhnout
2021-12-22 00:00:008-KStáhnout
2021-12-21 23:00:008-KStáhnout
2021-11-19 00:00:008-KStáhnout
2021-11-18 23:00:008-KStáhnout
2021-11-15 00:00:008-KStáhnout
2021-11-15 00:00:0010-QStáhnout
2021-11-14 23:00:008-KStáhnout
2021-11-14 23:00:0010-QStáhnout
2021-09-29 01:00:008-KStáhnout
2021-09-29 00:00:008-KStáhnout
2021-08-20 01:00:008-KStáhnout
2021-08-20 00:00:008-KStáhnout
2021-08-05 01:00:008-KStáhnout
2021-08-05 01:00:0010-QStáhnout
2021-08-05 00:00:008-KStáhnout
2021-08-05 00:00:0010-QStáhnout
2021-06-09 01:00:008-KStáhnout
2021-06-09 00:00:008-KStáhnout
2021-05-06 01:00:008-KStáhnout
2021-05-06 01:00:0010-QStáhnout
2021-05-06 00:00:008-KStáhnout
2021-05-06 00:00:0010-QStáhnout
2021-03-29 01:00:008-KStáhnout
2021-03-29 00:00:008-KStáhnout
2021-03-09 00:00:008-KStáhnout
2021-03-09 00:00:0010-KStáhnout
2021-03-08 23:00:008-KStáhnout
2021-03-08 23:00:0010-KStáhnout
2021-01-12 00:00:008-KStáhnout
2021-01-11 23:00:008-KStáhnout
2020-12-15 00:00:008-KStáhnout
2020-12-14 23:00:008-KStáhnout
2020-12-10 00:00:008-KStáhnout
2020-12-09 23:00:008-KStáhnout
2020-11-12 00:00:008-KStáhnout
2020-11-12 00:00:0010-QStáhnout
2020-11-11 23:00:008-KStáhnout
2020-11-11 23:00:0010-QStáhnout
2020-08-06 01:00:008-KStáhnout
2020-08-06 01:00:0010-QStáhnout
2020-08-06 00:00:008-KStáhnout
2020-08-06 00:00:0010-QStáhnout
2020-06-16 01:00:008-KStáhnout
2020-06-16 00:00:008-KStáhnout
2020-05-07 01:00:008-KStáhnout
2020-05-07 01:00:0010-QStáhnout
2020-05-07 00:00:008-KStáhnout
2020-05-07 00:00:0010-QStáhnout
2020-03-12 00:00:008-KStáhnout
2020-03-12 00:00:0010-KStáhnout
2020-03-11 23:00:008-KStáhnout
2020-03-11 23:00:0010-KStáhnout
2020-01-14 00:00:008-KStáhnout
2020-01-13 23:00:008-KStáhnout
2019-12-27 00:00:008-KStáhnout
2019-12-26 23:00:008-KStáhnout
2019-11-06 00:00:008-KStáhnout
2019-11-06 00:00:0010-QStáhnout
2019-11-05 23:00:008-KStáhnout
2019-11-05 23:00:0010-QStáhnout
2019-08-28 01:00:008-KStáhnout
2019-08-28 01:00:0010-QStáhnout
2019-08-28 00:00:008-KStáhnout
2019-08-28 00:00:0010-QStáhnout
2019-07-25 01:00:008-KStáhnout
2019-07-25 00:00:008-KStáhnout
preloader